These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 21918921

  • 1. Sulfobutyl ether(7) β-cyclodextrin (SBE(7) β-CD) carbamazepine complex: preparation, characterization, molecular modeling, and evaluation of in vivo anti-epileptic activity.
    Jain AS, Date AA, Pissurlenkar RR, Coutinho EC, Nagarsenker MS.
    AAPS PharmSciTech; 2011 Dec; 12(4):1163-75. PubMed ID: 21918921
    [Abstract] [Full Text] [Related]

  • 2. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.
    Devasari N, Dora CP, Singh C, Paidi SR, Kumar V, Sobhia ME, Suresh S.
    Carbohydr Polym; 2015 Dec 10; 134():547-56. PubMed ID: 26428157
    [Abstract] [Full Text] [Related]

  • 3. Carbamazepine/betaCD/HPMC solid dispersions. II. Physical characterization.
    Koester LS, Mayorga P, Pereira VP, Petzhold CL, Bassani VL.
    Drug Dev Ind Pharm; 2003 Feb 10; 29(2):145-54. PubMed ID: 12648011
    [Abstract] [Full Text] [Related]

  • 4. Characterization of the complexes of furosemide with 2-hydroxypropyl-beta-cyclodextrin and sulfobutyl ether-7-beta-cyclodextrin.
    Spamer E, Müller DG, Wessels PL, Venter JP.
    Eur J Pharm Sci; 2002 Sep 10; 16(4-5):247-53. PubMed ID: 12208454
    [Abstract] [Full Text] [Related]

  • 5. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
    Jadhav GS, Vavia PR.
    Int J Pharm; 2008 Mar 20; 352(1-2):5-16. PubMed ID: 18023545
    [Abstract] [Full Text] [Related]

  • 6. Characterization and molecular modeling of the inclusion complexes of 2-(2-nitrovinyl) furan (G-0) with cyclodextrines.
    Ruz V, Froeyen M, Busson R, González MM, Baudemprez L, Van den Mooter G.
    Int J Pharm; 2012 Dec 15; 439(1-2):275-85. PubMed ID: 22989977
    [Abstract] [Full Text] [Related]

  • 7. Influence of beta-cyclodextrin complexation on carbamazepine release from hydroxypropyl methylcellulose matrix tablets.
    Koester LS, Xavier CR, Mayorga P, Bassani VL.
    Eur J Pharm Biopharm; 2003 Jan 15; 55(1):85-91. PubMed ID: 12551708
    [Abstract] [Full Text] [Related]

  • 8. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM, Elkheshen SA, Ghorab MM.
    Eur J Pharm Biopharm; 2008 Nov 15; 70(3):819-27. PubMed ID: 18655829
    [Abstract] [Full Text] [Related]

  • 9. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
    Sherje AP, Kulkarni V, Murahari M, Nayak UY, Bhat P, Suvarna V, Dravyakar B.
    Mol Pharm; 2017 Apr 03; 14(4):1231-1242. PubMed ID: 28248111
    [Abstract] [Full Text] [Related]

  • 10. Docetaxel/dimethyl-β-cyclodextrin inclusion complexes: preparation, in vitro evaluation and physicochemical characterization.
    Giri BR, Lee J, Lim DY, Kim DW.
    Drug Dev Ind Pharm; 2021 Feb 03; 47(2):319-328. PubMed ID: 33576707
    [Abstract] [Full Text] [Related]

  • 11. Molecular simulation of hydroxypropyl-beta-cyclodextrin with hydrophobic selective Cox-II chemopreventive agent using host-guest phenomena.
    Sinha VR, Nanda A, Chadha R, Goel H.
    Acta Pol Pharm; 2011 Feb 03; 68(4):585-92. PubMed ID: 21796941
    [Abstract] [Full Text] [Related]

  • 12. Preparation & characterization of solid inclusion complex of cefpodoxime proxetil with beta-cyclodextrin.
    Bhargava S, Agrawal GP.
    Curr Drug Deliv; 2008 Jan 03; 5(1):1-6. PubMed ID: 18220545
    [Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo evaluation of novel immediate release carbamazepine tablets: complexation with hydroxypropyl-β-cyclodextrin in the presence of HPMC.
    Kou W, Cai C, Xu S, Wang H, Liu J, Yang D, Zhang T.
    Int J Pharm; 2011 May 16; 409(1-2):75-80. PubMed ID: 21371541
    [Abstract] [Full Text] [Related]

  • 14. Tablet formulation studies on an oxcarbazepine-beta cyclodextrin binary system.
    Patel NV, Chotai NP, Patel MP.
    Pharmazie; 2008 Apr 16; 63(4):275-81. PubMed ID: 18468386
    [Abstract] [Full Text] [Related]

  • 15. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A, Carvalho RA, Ribeiro L, Torres-Labandeira JJ, Veiga FJ.
    Eur J Pharm Biopharm; 2007 Sep 16; 67(2):531-9. PubMed ID: 17451924
    [Abstract] [Full Text] [Related]

  • 16. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
    Jug M, Maestrelli F, Bragagni M, Mura P.
    J Pharm Biomed Anal; 2010 May 01; 52(1):9-18. PubMed ID: 20004541
    [Abstract] [Full Text] [Related]

  • 17. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes.
    Desai C, Prabhakar B.
    Drug Dev Ind Pharm; 2015 May 01; 41(10):1589-607. PubMed ID: 25350555
    [Abstract] [Full Text] [Related]

  • 18. Inclusion Complexes of Hydroxy Propyl-β-Cyclodextrin and Paliperidone: Preparation and Characterization.
    Sherje A, Londhe V.
    Curr Drug Discov Technol; 2014 May 01; 11(4):271-8. PubMed ID: 25578059
    [Abstract] [Full Text] [Related]

  • 19. Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes.
    Sathigari S, Chadha G, Lee YH, Wright N, Parsons DL, Rangari VK, Fasina O, Babu RJ.
    AAPS PharmSciTech; 2009 May 01; 10(1):81-7. PubMed ID: 19148759
    [Abstract] [Full Text] [Related]

  • 20. Role of humic acid on oral drug delivery of an antiepileptic drug.
    Mirza MA, Agarwal SP, Rahman MA, Rauf A, Ahmad N, Alam A, Iqbal Z.
    Drug Dev Ind Pharm; 2011 Mar 01; 37(3):310-9. PubMed ID: 20815797
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.